UB
SRPT icon

UMB Bank’s Sarepta Therapeutics SRPT Stock Holding History

UMB Bank’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Sell
572
-219
-28% -$4.14K ﹤0.01% 1929
2026
Q1 		$17.2K Buy
791
+154
+24% +$2.98K ﹤0.01% 1653
2025
Q4 		$13.7K Sell
637
-203
-24% -$4.28K ﹤0.01% 1695
2025
Q3 		$16.2K Sell
840
-113
-12% -$2.01K ﹤0.01% 1514
2025
Q2 		$16.3K Buy
953
+156
+20% +$6.66K ﹤0.01% 1449
2025
Q1 		$50.9K Buy
797
+276
+53% +$29.1K ﹤0.01% 1045
2024
Q4 		$63.3K Buy
521
+138
+36% +$16.9K ﹤0.01% 821
2024
Q3 		$47.8K Buy
383
+197
+106% +$27.2K ﹤0.01% 888
2024
Q2 		$29.4K Buy
186
+47
+34% +$6.04K ﹤0.01% 956
2024
Q1 		$18K Hold
139
– – ﹤0.01% 1117
2023
Q4 		$13.4K Sell
139
-37
-21% -$3.55K ﹤0.01% 1193
2023
Q3 		$21.3K Hold
176
– – ﹤0.01% 1061
2023
Q2 		$20.2K Sell
176
-151
-46% -$19.5K ﹤0.01% 1094
2023
Q1 		$45.1K Hold
327
– – ﹤0.01% 861
2022
Q4 		$42K Hold
327
– – ﹤0.01% 893
2022
Q3 		$36K Sell
327
-50
-13% -$5.04K ﹤0.01% 951
2022
Q2 		$29K Sell
377
-379
-50% -$27.9K ﹤0.01% 1055
2022
Q1 		$59K Hold
756
– – ﹤0.01% 924
2021
Q4 		$69K Buy
+756
New +$64.6K ﹤0.01% 899

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

UMB Bank's SRPT Position: Q2 2026 in Review

UMB Bank reduced its Sarepta Therapeutics (SRPT) stake by 28% in Q2 2026, selling an estimated $4.14K and leaving 572 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1929.

UMB Bank first reported a position in SRPT in Q4 2021 and has held it in 19 quarters since. The position peaked at $69K in Q4 2021. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • UMB Bank held 572 shares of Sarepta Therapeutics worth $10.3K as of Q2 2026.
  • UMB Bank sold 219 Sarepta Therapeutics shares in Q2 2026, an estimated $4.14K.
  • Sarepta Therapeutics made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1929 holding.
  • UMB Bank first reported a position in Sarepta Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's Sarepta Therapeutics position peaked at $69K in Q4 2021.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.